SCHEMBL3206922

SCHEMBL3206922

O=C(NCCc1ccc(O)c(Br)c1)c1ccc[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.61
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA9 Q16790 2/20 0.49
CA12 O43570 1/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
PLK4 O00444 1/20 0.47
AURKA O14965 1/20 0.47
NUAK1 O60285 1/20 0.47
EGFR P00533 1/20 0.47
ERBB2 P04626 1/20 0.47
INSR P06213 1/20 0.47
IGF1R P08069 1/20 0.47
MET P08581 1/20 0.47
PDGFRB P09619 1/20 0.47
CDK4 P11802 1/20 0.47
SRC P12931 1/20 0.47
BRAF P15056 1/20 0.47
CCNA2 P20248 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13486628 0.83 HRH3 (0.62) HRH3CA1CA2CA9CA12
SCHEMBL3208982 0.83 HRH3 (0.72) HRH3KDM4ELMNAHDAC3HDAC4
SCHEMBL27944339 0.77 PLK4 (0.55) CA1CA2CA9CA12KDM4E
SCHEMBL3193150 0.77 HRH3 (1.00) HRH3
SCHEMBL29210589 0.76 KDM4E (0.73) CA1CA2CA9CA12KDM4E
SCHEMBL30983754 0.76 KDM4E (0.73) CA1CA2CA9CA12KDM4E
SCHEMBL4563222 0.76 HRH3 (0.76) HRH3
SCHEMBL3192205 0.76 HRH3 (1.00) HRH3
SCHEMBL3200646 0.76 HPGD (0.66) HRH3LMNAPLK4AURKANUAK1
SCHEMBL3193396 0.74 HRH3 (1.00) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 US disclosed
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 US disclosed
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY 2010-02-11 US disclosed
WO-2009152071-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY (US) 2009-12-17 WO disclosed
WO-2009152071-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF VANDERBILT UNIVERSITY (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035929-A1 UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF HRH3, HRH4, HRH1 HRH3 1/4885CA1 478/4885CA2 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.